πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9487753

Compositions of adult disc stem cells and methods for the treatment of degenerative disc d

DiscGenics, Inc. Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9487575

Compositions and methods for treatment of gynecologic cancers

The Regents of the University of California Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9486456

Treatment of esophageal motility disorder using sepiapterin, tetrahydrobiopterin and deriv

The Board of Regents of the University of Texas System Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9480725

Fermented wheat germ proteins (FWGP) for the treatment of cancer

The Regents of the University of California Β· Granted Tue Nov 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9481692

Heterocyclic modulators of HIF activity for treatment of disease

The Board of Regents of the University of Texas System Β· Granted Tue Nov 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9474743

Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease

PTC THERAPEUTICS, INC. Β· Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9476047

RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions

Arrowhead Pharmaceuticals, Inc. Β· Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9475871

Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins

Five Prime Therapeutics, Inc. Β· Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9475832

Phosphonates with reduced toxicity for treatment of viral infections

The Regents of the University of California Β· Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9474793

Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9474787

Mesenchymal stem cells for the treatment of CNS diseases

BRAINSTORM CELL THERAPEUTICS LTD. Β· Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9468611

d-Methadone for the treatment of psychiatric symptoms

Relmada Therapeutics, Inc. Β· Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9463193

Individual 5-fluorouracile dose optimization in folfiri treatment

INSTITUT DE CANCEROLOGIE DE L'OUEST Β· Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9463186

Treatment for dopaminergic disorders

Northwestern University Β· Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9457006

Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tr

The Regents of the University of California Β· Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9458507

Antipsychotic treatment based on SNP genotype

VANDA PHARMACEUTICALS INC. Β· Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9457070

Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marro

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9457030

Compositions and methods for the treatment of juvenile neuronal ceroid lipofuscinosis and

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9456997

Selective inhibition of Ξ²1-adrenergic receptors for the treatment of pediatric heart failu

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9453220

RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular

Arrowhead Pharmaceuticals, Inc. Β· Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9452175

Pregnancy hormone combination for treatment of autoimmune diseases

The Regents of the University of California Β· Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9445870

Methods and devices for crosslinking of corneal collagen and for treatment of disorders of

Montefiore Medical Center Β· Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9447406

Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9446037

Methods for the treatment of parkinson's disease psychosis using pimavanserin

ACADIA Pharmaceuticals Inc. Β· Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted